| Catelog# |
Product |
CAS# |
Formula |
Purity(%) |
Inquiry |
First Page Previous Page [661] [662] [663] 664 [665] [666] [667] [668] Next Page Last Page Total 17946 items, Total 718 Page Goto
| 2A-3185534 |
4-Bromo-6-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile |
1822680-43-2 |
|
0% |
Inquiry |
| 2A-3185535 |
6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile |
1207836-10-9 |
|
0% |
Inquiry |
| 2A-3185536 |
Semaglutide intermediate |
1118767-15-9 |
|
0% |
Inquiry |
| 2A-3185537 |
ROC-325 |
1859141-26-6 |
|
0% |
Inquiry |
| 2A-3185538 |
N2-(7-Chloro-4-quinolinyl)-N1-[2-[(7-chloro-4-quinolinyl)aMino]ethyl]-N1-Methyl-1,2-ethanediaMine |
1391426-22-4 |
|
0% |
Inquiry |
| 2A-3185539 |
1,4:3,6-dianhydro-D-threo-hexo-2,5-diulose |
13241-36-6 |
|
0% |
Inquiry |
| 2A-3185540 |
NPS-1034 |
1221713-92-3 |
|
0% |
Inquiry |
| 2A-3185541 |
Vps |
1383716-46-8 |
|
0% |
Inquiry |
| 2A-3185542 |
PD0166285 |
185039-89-8 |
|
0% |
Inquiry |
| 2A-3185543 |
KX2-391 |
897016-82-9 |
|
0% |
Inquiry |
| 2A-3185544 |
5(6)-(N-SUCCINIMIDYLOXYCARBONYL)-3',6',O,O'-DIACETYLFLUORESCEIN |
150347-59-4 |
|
0% |
Inquiry |
| 2A-3185545 |
FIPI |
939055-18-2 |
|
0% |
Inquiry |
| 2A-3185546 |
ROCK inhibitor 2 |
911417-87-3 |
|
0% |
Inquiry |
| 2A-3185547 |
PIK-III |
1383716-40-2 |
|
0% |
Inquiry |
| 2A-3185548 |
Vps34-IN-1 |
1383716-33-3 |
|
0% |
Inquiry |
| 2A-3185549 |
4-(Nitrooxy)butan-1-ol |
22911-39-3 |
|
0% |
Inquiry |
| 2A-3185550 |
(R)-(+)-α-Phenylethylamine |
2A-3185550 |
|
0% |
Inquiry |
| 2A-3185551 |
ALLYL 2-FUROATE |
4208-49-5 |
|
0% |
Inquiry |
| 2A-3185552 |
DMDPB |
2A-3185552 |
|
0% |
Inquiry |
| 2A-3185553 |
Linagliptin iMpurity |
2140263-92-7 |
|
0% |
Inquiry |
| 2A-3185554 |
Cefalexin IMpurity ( 3-aMinoMethylene-6-phenylpiperazine-2,5-dione) |
65870-51-1 |
|
0% |
Inquiry |
| 2A-3185555 |
Vortioxetine iMpurity |
853745-55-8 |
|
0% |
Inquiry |
| 2A-3185556 |
Ritonavir IMpurity |
1010809-54-7 |
|
0% |
Inquiry |
| 2A-3185557 |
Gefitinib iMpurity |
1608115-59-8 |
|
0% |
Inquiry |
| 2A-3185558 |
Gabapentin Related Compound E |
67950-95-2 |
|
0% |
Inquiry |
| |
|
|
|
